HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Earnings In Brief

This article was originally published in The Rose Sheet

Executive Summary

Schering-Plough: Sun care sales soared 60% to $78 mil. in the second quarter, "due to the timing of orders and shipments, coupled with favorable weather conditions," Coppertone marketer reports July 21. Consumer health care sales rose 19% to $317 mil., firm adds. Schering has "good work underway" on new Coppertone and Dr. Scholl's extensions, CEO Fred Hassan says during July 21 earnings call. However, consumer health gains were offset by struggles in Rx pharmaceuticals, spending connected to an FDA consent decree and restructuring costs, company states. Firm reports 7% net sales decline to $2.1 bil. and net loss of $65 mil...
Advertisement

Related Content

LVMH 91% Retail Operating Income Gain Signals Sephora Viability
Schering Consent Decree Is Weighing Down Operations, CEO Says
LVMH 91% Retail Operating Income Gain Signals Sephora Viability
Schering Consent Decree Is Weighing Down Operations, CEO Says
Advertisement
UsernamePublicRestriction

Register

RS012318

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel